Indivior Pharmaceuticals, Inc. (INDV) /
The revenue of Indivior Pharmaceuticals, Inc. over the past 4 years
Chart Indivior Pharmaceuticals, Inc.: revenue, fiscal 2022–2025 Open the chart →Indivior Pharmaceuticals, Inc. reported revenue of $1.24B in fiscal 2025, the latest fiscal year on file. In fiscal 2022 it was $901M — up 38% over 3 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2023: up 21%, from $901M to $1.09B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $1.24B |
| 2024ended Dec 31, 2024 | $1.19B |
| 2023ended Dec 31, 2023 | $1.09B |
| 2022ended Dec 31, 2022 | $901M |
Fiscal years as Indivior Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Indivior Pharmaceuticals, Inc.
- The profitability of Indivior Pharmaceuticals, Inc.
- The cash flow of Indivior Pharmaceuticals, Inc.
- All of Indivior Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- LOPEGRAND CANYON EDUCATION, INC.
- CORZCore Scientific, Inc./tx
- CRVLCORVEL CORPORATION
- APLEAPPLE HOSPITALITY REIT, INC.
- KGSKodiak Gas Services, Inc.
Not investment advice. This page shows what Indivior Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.